Machine-Speed Responses to Payer Denials
Denial management wasn’t designed for today’s payer environment.
Payer adjudication now runs at machine speed. Hospital appeals do not. That mismatch creates backlogs, delays recovery, and leaves revenue stranded.
DAA was built for this reality—bringing speed and judgment directly into denial workflows.
See how DAA works
Recover denied revenue faster while improving predictability of cash flow-without adding headcount or extending AR.
Reduce manual triage and focus expert effort on high-value, winnable appeals- so time is spent where recovery is most likely.
Scale appeal throughput, shorten appeal cycles, and eliminate backlogs by aligning people, process, and AI around the appeals that matter.
72x
Faster appeal cycle time
25%
Improvement in overturn rates on high-value denials
60%
Reduction in denial backlogs and write-offs
30%
Reduction in denial-related AR days
Based on prioritized, actionable denials; results may vary by payer mix and appeal type.
A New Layer of Appeal Decisioning
DAA introduces a decision layer that sits above traditional denial workflows.
Instead of treating every denial as an automatic appeal, the platform evaluates recovery potential and timing before action is taken. This gives hospitals clarity on where appeal effort belongs and where it does not—so decisions are intentional, not habitual.
Appeals start with judgment, not volume.
A New Execution Model for Appeals
DAA replaces manual handoffs with an agent-driven execution model.
Intelligent agents advance appeal work while expert coders and clinicians apply oversight and judgment at the right moments. Appeals move forward in a coordinated, disciplined way—without adding staff or sacrificing quality.
This is not faster work. It’s a different way the work gets done.
Appeals as Financial Control
DAA treats denial appeals as managed financial exposure.
Appeal effort is aligned to recovery impact and time sensitivity, allowing hospitals to actively control write-offs and cash recovery rather than reacting to backlogs. Resources are applied where they change outcomes, not spread thin across every denial.
Denials stop being noise. They become something finance can manage.
The investigation has triggered bipartisan concern, with lawmakers scrutinizing whether risk adjustment practices have crossed ethical lines. The move signals a shift from passive oversight to active enforcement, putting the future of MA funding and the industry's credibility at a tipping point.
Continue Reading ›
The investigation has triggered bipartisan concern, with lawmakers scrutinizing whether risk adjustment practices have crossed ethical lines. The move signals a shift from passive oversight to active enforcement, putting the future of MA funding and the industry's credibility at a tipping point.
Continue Reading ›
The investigation has triggered bipartisan concern, with lawmakers scrutinizing whether risk adjustment practices have crossed ethical lines. The move signals a shift from passive oversight to active enforcement, putting the future of MA funding and the industry's credibility at a tipping point.
Continue Reading ›